• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二硫苏糖醇(DTE)偶联脱氧核糖环二核苷酸前药(DTE-dCDNs)作为 STING 激动剂。

Dithioethanol (DTE)-Conjugated Deoxyribose Cyclic Dinucleotide Prodrugs (DTE-dCDNs) as STING Agonist.

机构信息

State Key Laboratory of Elemento-Organic Chemistry, Department of Chemical Biology, College of Chemistry, Nankai University, Tianjin 300071, China.

Frontiers Science Center for New Organic Matter, Nankai University, Tianjin 300071, China.

出版信息

Int J Mol Sci. 2023 Dec 20;25(1):86. doi: 10.3390/ijms25010086.

DOI:10.3390/ijms25010086
PMID:38203256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10778758/
Abstract

To improve the chemical regulation on the activity of cyclic dinucleotides (CDNs), we here designed a reduction-responsive dithioethanol (DTE)-based dCDN prodrug (DTE-dCDN). Prodrug improved the cell permeability with the intracellular levels peaking in 2 h in THP-1 cells. Under the reductive substance such as GSH or DTT, prodrug could be quickly decomposed in 30 min to release the parent dCDN. In THP1-Lucia cells, prodrug also retained a high bioactivity with the EC of 0.96 μM, which was 51-, 43-, and 3-fold more than the 2',3'-cGAMP (EC = 48.6 μM), the parent compound 3',3'-c-di-dAMP (EC = 41.3 μM), and ADU-S100 (EC = 2.9 μM). The high bioactivity of prodrug was validated to be highly correlated with the activation of the STING signaling pathway. Furthermore, prodrug could also improve the transcriptional expression levels of , , and in THP-1 cells. These results will be helpful to the development of chemically controllable CDN prodrugs with a high cellular permeability and potency.

摘要

为了提高环状二核苷酸(CDNs)的化学调控活性,我们设计了一种基于还原响应性二硫乙醇(DTE)的 dCDN 前药(DTE-dCDN)。前药提高了细胞通透性,在 THP-1 细胞中 2 小时内达到细胞内浓度峰值。在 GSH 或 DTT 等还原物质存在的情况下,前药可以在 30 分钟内迅速分解,释放出母体 dCDN。在 THP1-Lucia 细胞中,前药也保持了高生物活性,EC 值为 0.96 μM,是 2',3'-cGAMP(EC = 48.6 μM)、母体化合物 3',3'-c-di-dAMP(EC = 41.3 μM)和 ADU-S100(EC = 2.9 μM)的 51、43 和 3 倍。前药的高生物活性被证实与 STING 信号通路的激活高度相关。此外,前药还可以提高 THP-1 细胞中 、 、 和 的转录表达水平。这些结果将有助于开发具有高细胞通透性和效力的化学可控 CDN 前药。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/7ac7a76bb22f/ijms-25-00086-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/45206b5925cc/ijms-25-00086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/c6c2a421dbab/ijms-25-00086-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/75e5bd610737/ijms-25-00086-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/f09caaf9fbf2/ijms-25-00086-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/9f71b00c6705/ijms-25-00086-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/096b01a3fdee/ijms-25-00086-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/54eb22b99839/ijms-25-00086-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/e54421aa9548/ijms-25-00086-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/475882909c80/ijms-25-00086-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/7ac7a76bb22f/ijms-25-00086-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/45206b5925cc/ijms-25-00086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/c6c2a421dbab/ijms-25-00086-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/75e5bd610737/ijms-25-00086-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/f09caaf9fbf2/ijms-25-00086-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/9f71b00c6705/ijms-25-00086-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/096b01a3fdee/ijms-25-00086-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/54eb22b99839/ijms-25-00086-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/e54421aa9548/ijms-25-00086-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/475882909c80/ijms-25-00086-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/10778758/7ac7a76bb22f/ijms-25-00086-g009.jpg

相似文献

1
Dithioethanol (DTE)-Conjugated Deoxyribose Cyclic Dinucleotide Prodrugs (DTE-dCDNs) as STING Agonist.二硫苏糖醇(DTE)偶联脱氧核糖环二核苷酸前药(DTE-dCDNs)作为 STING 激动剂。
Int J Mol Sci. 2023 Dec 20;25(1):86. doi: 10.3390/ijms25010086.
2
S-acylthioalkyl ester (SATE)-based prodrugs of deoxyribose cyclic dinucleotides (dCDNs) as the STING agonist for antitumor immunotherapy.基于 S-酰硫基烷基酯(SATE)的脱氧核糖环二核苷酸(dCDNs)前药作为 STING 激动剂用于抗肿瘤免疫治疗。
Eur J Med Chem. 2022 Dec 5;243:114796. doi: 10.1016/j.ejmech.2022.114796. Epub 2022 Sep 28.
3
Design, synthesis, and cell-based assay of deoxyinosine-mixed SATE-dCDN prodrugs that activate all common STING variants.可激活所有常见STING变体的脱氧肌苷混合SATE-dCDN前药的设计、合成及基于细胞的分析
Org Biomol Chem. 2024 Jan 17;22(3):606-620. doi: 10.1039/d3ob01838e.
4
Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential.发现具有免疫调节潜力的同核苷型环状二核苷酸作为有效的 STING 激动剂。
Structure. 2022 Aug 4;30(8):1146-1156.e11. doi: 10.1016/j.str.2022.05.012. Epub 2022 Jun 10.
5
Vinylphosphonate-based cyclic dinucleotides enhance STING-mediated cancer immunotherapy.基于膦酸酯的环状二核苷酸增强 STING 介导的癌症免疫治疗。
Eur J Med Chem. 2023 Nov 5;259:115685. doi: 10.1016/j.ejmech.2023.115685. Epub 2023 Jul 26.
6
Synthesis and Biological Evaluation of Phosphoester and Phosphorothioate Prodrugs of STING Agonist 3',3'-c-Di(2'F,2'dAMP).STING 激动剂 3',3'-c-二(2'F,2'dAMP)的磷酸酯和硫代磷酸酯前药的合成与生物学评价。
J Med Chem. 2021 Jun 10;64(11):7596-7616. doi: 10.1021/acs.jmedchem.1c00301. Epub 2021 May 21.
7
Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy.聚合物囊泡介导的环状二核苷酸STING激动剂的胞质递送增强肿瘤免疫治疗。
Bioact Mater. 2022 Mar 4;16:1-11. doi: 10.1016/j.bioactmat.2022.02.029. eCollection 2022 Oct.
8
Crystal structures of porcine STING-CDN complexes reveal the mechanism of ligand recognition and discrimination of STING proteins.猪 STING-CDN 复合物的晶体结构揭示了 STING 蛋白配体识别和区分的机制。
J Biol Chem. 2019 Jul 26;294(30):11420-11432. doi: 10.1074/jbc.RA119.007367. Epub 2019 Jun 5.
9
Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potential Immunotherapy for Prostate Cancer.白细胞介素-15与STING激动剂ADU-S100类似物联合应用:前列腺癌的一种潜在免疫疗法。
Front Oncol. 2021 Mar 10;11:621550. doi: 10.3389/fonc.2021.621550. eCollection 2021.
10
The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells.模拟物 cGAMP,c-di-AMP,激活雌激素受体阴性乳腺癌细胞中的 STING 介导的细胞死亡途径。
Apoptosis. 2021 Jun;26(5-6):293-306. doi: 10.1007/s10495-021-01669-x. Epub 2021 Apr 10.

引用本文的文献

1
The Application and Limitations of Promising Biological Therapies in Livestock Production under the Context of Antibiotic Restrictions.抗生素限制背景下有前景的生物疗法在畜牧生产中的应用与局限
Probiotics Antimicrob Proteins. 2025 Aug 14. doi: 10.1007/s12602-025-10705-0.
2
Conjugated STING agonists.共轭STING激动剂。
Mol Ther Nucleic Acids. 2025 Mar 31;36(2):102530. doi: 10.1016/j.omtn.2025.102530. eCollection 2025 Jun 10.
3
Review of Prodrug and Nanodelivery Strategies to Improve the Treatment of Colorectal Cancer with Fluoropyrimidine Drugs.

本文引用的文献

1
S-acylthioalkyl ester (SATE)-based prodrugs of deoxyribose cyclic dinucleotides (dCDNs) as the STING agonist for antitumor immunotherapy.基于 S-酰硫基烷基酯(SATE)的脱氧核糖环二核苷酸(dCDNs)前药作为 STING 激动剂用于抗肿瘤免疫治疗。
Eur J Med Chem. 2022 Dec 5;243:114796. doi: 10.1016/j.ejmech.2022.114796. Epub 2022 Sep 28.
2
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.化学和生物分子策略在癌症免疫治疗中对 STING 通路的激活。
Chem Rev. 2022 Mar 23;122(6):5977-6039. doi: 10.1021/acs.chemrev.1c00750. Epub 2022 Feb 2.
3
Synthesis and Biological Evaluation of Phosphoester and Phosphorothioate Prodrugs of STING Agonist 3',3'-c-Di(2'F,2'dAMP).
前药与纳米给药策略综述:改善氟嘧啶类药物治疗结直肠癌的疗效
Pharmaceutics. 2024 May 29;16(6):734. doi: 10.3390/pharmaceutics16060734.
STING 激动剂 3',3'-c-二(2'F,2'dAMP)的磷酸酯和硫代磷酸酯前药的合成与生物学评价。
J Med Chem. 2021 Jun 10;64(11):7596-7616. doi: 10.1021/acs.jmedchem.1c00301. Epub 2021 May 21.
4
Synthesis and biological evaluation of all possible inosine-mixed cyclic dinucleotides that activate different hSTING variants.合成并评估所有可能的混合肌苷环二核苷酸,以激活不同的 hSTING 变体。
Bioorg Med Chem. 2021 Jan 1;29:115899. doi: 10.1016/j.bmc.2020.115899. Epub 2020 Nov 26.
5
The Age of Cyclic Dinucleotide Vaccine Adjuvants.环二核苷酸疫苗佐剂时代。
Vaccines (Basel). 2020 Aug 13;8(3):453. doi: 10.3390/vaccines8030453.
6
Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective.靶向干扰素基因刺激物(STING):药物化学视角。
J Med Chem. 2020 Apr 23;63(8):3785-3816. doi: 10.1021/acs.jmedchem.9b01039. Epub 2019 Dec 20.
7
SLC19A1 transports immunoreactive cyclic dinucleotides.SLC19A1 转运免疫反应性环二核苷酸。
Nature. 2019 Sep;573(7774):434-438. doi: 10.1038/s41586-019-1553-0. Epub 2019 Sep 11.
8
Targeting STING with covalent small-molecule inhibitors.靶向 STING 的共价小分子抑制剂。
Nature. 2018 Jul;559(7713):269-273. doi: 10.1038/s41586-018-0287-8. Epub 2018 Jul 4.
9
Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.基于二硫键的氧化还原响应前药纳米组装体用于癌症治疗。
Nano Lett. 2018 Jun 13;18(6):3643-3650. doi: 10.1021/acs.nanolett.8b00737. Epub 2018 May 9.
10
The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles.连接子对二硫键连接的阿霉素药物-药物偶联纳米粒自组装和抗肿瘤功效的影响。
J Control Release. 2018 Jun 10;279:136-146. doi: 10.1016/j.jconrel.2018.04.019. Epub 2018 Apr 12.